CNCT19 CAR-T cell therapy
IIT2024003
Phase 1 mab active
Quick answer
CNCT19 CAR-T cell therapy for Autoimmune Hemolytic Anemia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Autoimmune Hemolytic Anemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active